EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
Nomura K, Aokage K, Kaminuma Y, Nakai T, Wakabayashi M, Ikeno T, Koike Y, Taki T, Miyoshi T, Tane K, Samejima J, Ishii G, Tsuboi M.
Nomura K, et al. Among authors: aokage k.
Int J Clin Oncol. 2024 Mar;29(3):248-257. doi: 10.1007/s10147-023-02464-1. Epub 2024 Feb 6.
Int J Clin Oncol. 2024.
PMID: 38319510